世界のビカルタミド市場予測（～2028年）：錠剤、カプセル剤

• 英文タイトル：Global Bicalutamide Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8750 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ビカルタミド市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のビカルタミドの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ビカルタミド市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・錠剤、カプセル剤 用途別セグメントは次のように区分されます。 ・前立腺癌向け単剤治療、前立腺癌向け化学療法併用、前立腺癌向け放射線療法/去勢手術併用 世界のビカルタミド市場の主要な市場プレーヤーは以下のとおりです。 ・AstraZeneca、CORDEN PHARMA GMBH、Zeneca GmbH、Actavis Pharma、Sivem Pharmaceuticals、Sorres Pharma、Fresenius Kabi、ANI Pharmaceuticals、Accel Pharma、Apotex Corporation、Shanghai Fudan Fuhua Pharmaceutical、Shanghai Zhaohui Pharmaceutical、Zhejiang Haizheng Pharmaceutical、Shanxi Zhendong Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ビカルタミド製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なビカルタミドメーカーの企業概要、2019年～2022年までのビカルタミドの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なビカルタミドメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別ビカルタミドの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのビカルタミドの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのビカルタミド市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびビカルタミドの産業チェーンを掲載しています。 ・第13、14、15章では、ビカルタミドの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca、CORDEN PHARMA GMBH、Zeneca GmbH、Actavis Pharma、Sivem Pharmaceuticals、Sorres Pharma、Fresenius Kabi、ANI Pharmaceuticals、Accel Pharma、Apotex Corporation、Shanghai Fudan Fuhua Pharmaceutical、Shanghai Zhaohui Pharmaceutical、Zhejiang Haizheng Pharmaceutical、Shanxi Zhendong Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：錠剤、カプセル剤 ・用途別分析2017年-2028年：前立腺癌向け単剤治療、前立腺癌向け化学療法併用、前立腺癌向け放射線療法/去勢手術併用 ・ビカルタミドの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・ビカルタミドのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・ビカルタミドのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ビカルタミドの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・ビカルタミドの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Bicalutamide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Bicalutamide market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Single Drug For Prostate Cancer accounting for % of the Bicalutamide global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablets segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Bicalutamide include AstraZeneca, CORDEN PHARMA GMBH, Zeneca GmbH, Actavis Pharma, and Sivem Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Bicalutamide market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablets
Capsule
Market segment by Application can be divided into
Single Drug For Prostate Cancer
Combined Chemotherapy For Prostate Cancer
Combined Radiation Therapy Or Castration For Prostate Cancer
The key market players for global Bicalutamide market are listed below:
AstraZeneca
CORDEN PHARMA GMBH
Zeneca GmbH
Actavis Pharma
Sivem Pharmaceuticals
Sorres Pharma
Fresenius Kabi
ANI Pharmaceuticals
Accel Pharma
Apotex Corporation
Shanghai Fudan Fuhua Pharmaceutical
Shanghai Zhaohui Pharmaceutical
Zhejiang Haizheng Pharmaceutical
Shanxi Zhendong Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bicalutamide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bicalutamide, with price, sales, revenue and global market share of Bicalutamide from 2019 to 2022.
Chapter 3, the Bicalutamide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bicalutamide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Bicalutamide market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bicalutamide.
Chapter 13, 14, and 15, to describe Bicalutamide sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Bicalutamide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bicalutamide Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Tablets
1.2.3 Capsule
1.3 Market Analysis by Application
1.3.1 Overview: Global Bicalutamide Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Single Drug For Prostate Cancer
1.3.3 Combined Chemotherapy For Prostate Cancer
1.3.4 Combined Radiation Therapy Or Castration For Prostate Cancer
1.4 Global Bicalutamide Market Size & Forecast
1.4.1 Global Bicalutamide Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Bicalutamide Sales in Volume (2017-2028)
1.4.3 Global Bicalutamide Price (2017-2028)
1.5 Global Bicalutamide Production Capacity Analysis
1.5.1 Global Bicalutamide Total Production Capacity (2017-2028)
1.5.2 Global Bicalutamide Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bicalutamide Market Drivers
1.6.2 Bicalutamide Market Restraints
1.6.3 Bicalutamide Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Bicalutamide Product and Services
2.1.4 AstraZeneca Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CORDEN PHARMA GMBH
2.2.1 CORDEN PHARMA GMBH Details
2.2.2 CORDEN PHARMA GMBH Major Business
2.2.3 CORDEN PHARMA GMBH Bicalutamide Product and Services
2.2.4 CORDEN PHARMA GMBH Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Zeneca GmbH
2.3.1 Zeneca GmbH Details
2.3.2 Zeneca GmbH Major Business
2.3.3 Zeneca GmbH Bicalutamide Product and Services
2.3.4 Zeneca GmbH Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Actavis Pharma
2.4.1 Actavis Pharma Details
2.4.2 Actavis Pharma Major Business
2.4.3 Actavis Pharma Bicalutamide Product and Services
2.4.4 Actavis Pharma Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sivem Pharmaceuticals
2.5.1 Sivem Pharmaceuticals Details
2.5.2 Sivem Pharmaceuticals Major Business
2.5.3 Sivem Pharmaceuticals Bicalutamide Product and Services
2.5.4 Sivem Pharmaceuticals Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sorres Pharma
2.6.1 Sorres Pharma Details
2.6.2 Sorres Pharma Major Business
2.6.3 Sorres Pharma Bicalutamide Product and Services
2.6.4 Sorres Pharma Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Fresenius Kabi
2.7.1 Fresenius Kabi Details
2.7.2 Fresenius Kabi Major Business
2.7.3 Fresenius Kabi Bicalutamide Product and Services
2.7.4 Fresenius Kabi Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 ANI Pharmaceuticals
2.8.1 ANI Pharmaceuticals Details
2.8.2 ANI Pharmaceuticals Major Business
2.8.3 ANI Pharmaceuticals Bicalutamide Product and Services
2.8.4 ANI Pharmaceuticals Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Accel Pharma
2.9.1 Accel Pharma Details
2.9.2 Accel Pharma Major Business
2.9.3 Accel Pharma Bicalutamide Product and Services
2.9.4 Accel Pharma Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Apotex Corporation
2.10.1 Apotex Corporation Details
2.10.2 Apotex Corporation Major Business
2.10.3 Apotex Corporation Bicalutamide Product and Services
2.10.4 Apotex Corporation Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Shanghai Fudan Fuhua Pharmaceutical
2.11.1 Shanghai Fudan Fuhua Pharmaceutical Details
2.11.2 Shanghai Fudan Fuhua Pharmaceutical Major Business
2.11.3 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product and Services
2.11.4 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Shanghai Zhaohui Pharmaceutical
2.12.1 Shanghai Zhaohui Pharmaceutical Details
2.12.2 Shanghai Zhaohui Pharmaceutical Major Business
2.12.3 Shanghai Zhaohui Pharmaceutical Bicalutamide Product and Services
2.12.4 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Zhejiang Haizheng Pharmaceutical
2.13.1 Zhejiang Haizheng Pharmaceutical Details
2.13.2 Zhejiang Haizheng Pharmaceutical Major Business
2.13.3 Zhejiang Haizheng Pharmaceutical Bicalutamide Product and Services
2.13.4 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Shanxi Zhendong Pharmaceutical
2.14.1 Shanxi Zhendong Pharmaceutical Details
2.14.2 Shanxi Zhendong Pharmaceutical Major Business
2.14.3 Shanxi Zhendong Pharmaceutical Bicalutamide Product and Services
2.14.4 Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Bicalutamide Breakdown Data by Manufacturer
3.1 Global Bicalutamide Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Bicalutamide Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Bicalutamide
3.4 Market Concentration Rate
3.4.1 Top 3 Bicalutamide Manufacturer Market Share in 2021
3.4.2 Top 6 Bicalutamide Manufacturer Market Share in 2021
3.5 Global Bicalutamide Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Bicalutamide Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bicalutamide Market Size by Region
4.1.1 Global Bicalutamide Sales in Volume by Region (2017-2028)
4.1.2 Global Bicalutamide Revenue by Region (2017-2028)
4.2 North America Bicalutamide Revenue (2017-2028)
4.3 Europe Bicalutamide Revenue (2017-2028)
4.4 Asia-Pacific Bicalutamide Revenue (2017-2028)
4.5 South America Bicalutamide Revenue (2017-2028)
4.6 Middle East and Africa Bicalutamide Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Bicalutamide Sales in Volume by Type (2017-2028)
5.2 Global Bicalutamide Revenue by Type (2017-2028)
5.3 Global Bicalutamide Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Bicalutamide Sales in Volume by Application (2017-2028)
6.2 Global Bicalutamide Revenue by Application (2017-2028)
6.3 Global Bicalutamide Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Bicalutamide Sales by Type (2017-2028)
7.2 North America Bicalutamide Sales by Application (2017-2028)
7.3 North America Bicalutamide Market Size by Country
7.3.1 North America Bicalutamide Sales in Volume by Country (2017-2028)
7.3.2 North America Bicalutamide Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Bicalutamide Sales by Type (2017-2028)
8.2 Europe Bicalutamide Sales by Application (2017-2028)
8.3 Europe Bicalutamide Market Size by Country
8.3.1 Europe Bicalutamide Sales in Volume by Country (2017-2028)
8.3.2 Europe Bicalutamide Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Bicalutamide Sales by Type (2017-2028)
9.2 Asia-Pacific Bicalutamide Sales by Application (2017-2028)
9.3 Asia-Pacific Bicalutamide Market Size by Region
9.3.1 Asia-Pacific Bicalutamide Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Bicalutamide Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Bicalutamide Sales by Type (2017-2028)
10.2 South America Bicalutamide Sales by Application (2017-2028)
10.3 South America Bicalutamide Market Size by Country
10.3.1 South America Bicalutamide Sales in Volume by Country (2017-2028)
10.3.2 South America Bicalutamide Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bicalutamide Sales by Type (2017-2028)
11.2 Middle East & Africa Bicalutamide Sales by Application (2017-2028)
11.3 Middle East & Africa Bicalutamide Market Size by Country
11.3.1 Middle East & Africa Bicalutamide Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Bicalutamide Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Bicalutamide and Key Manufacturers
12.2 Manufacturing Costs Percentage of Bicalutamide
12.3 Bicalutamide Production Process
12.4 Bicalutamide Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Bicalutamide Typical Distributors
13.3 Bicalutamide Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---